Phase 1b dose-finding study of rituximab, lenalidomide, and ibrutinib (R2I) in patients with relapsed/refractory mantle cell lymphoma-Reference-Cited by-同舟云学术

Phase 1b dose-finding study of rituximab, lenalidomide, and ibrutinib (R2I) in patients with relapsed/refractory mantle cell lymphoma

Published:2023-09-23 Issue:14 Volume:64 Page:2225-2235
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Ip Andrew¹²³,Petrillo Alessandra¹,Della Pia Alexandra¹³^ORCID,Lee Geeny G.¹⁴^ORCID,Gill Sarvarinder¹,Varughese Tony¹,Zenreich Joshua¹³,Gutierrez Martin¹³,Zhang Jiayu⁴,Ahn Jaeil⁵,Bharani Vishnu²,Nejad Ava S.²,Pascual Lauren³,Feldman Tatyana A.¹²³,Leslie Lori A.¹²³,Goy Andre H.¹²³

Affiliation:

1. Division of Oncology, Hackensack University Medical Center, Hackensack, NJ, USA

2. Department of Oncology, Hackensack Meridian School of Medicine, Nutley, NJ, USA

3. John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA

4. Department of Pharmacy Practice & Administration, Ernest Mario School of Pharmacy at Rutgers University, Piscataway, NJ, USA

5. Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC, USA

Funder

Celgene

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2023.2259528

Reference33 articles.

1. Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004

2. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011

3. Mantle cell lymphoma: The promise of new treatment options

4. Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

5. Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SOHO State of the Art Updates and Next Questions: Treatment Evolution of Mantle Cell Lymphoma: Navigating the Different Entities and Biological Heterogeneity of Mantle Cell Lymphoma in 2024;Clinical Lymphoma Myeloma and Leukemia;2024-08